Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin injection into bilateral external oblique muscle for camptocormia in Parkinson's disease
jRCT1090220371Completed
- Sponsor
- Hyogo-Chuo National Hospital
- Start
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of neuronox in Parkinson's disease (PD) and camptocormia, sponsored by Hyogo-Chuo National Hospital. Primary endpoints: Change in camptocormia-related complaints and physical examination findings and Change in spinal bending angle. Started Jul 2018; status: completed.
02
Drugs
neuronox
03
Conditions
Parkinson's disease (PD)camptocormia
Beyond the preview
Go deeper on jRCT1090220371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220371.